{"brief_title": "Study Comparing Tigecycline to Imipenem/Cilastatin in Complicated Intra-Abdominal Infections in Hospitalized Subjects", "brief_summary": "Purpose: To provide a mechanism for the emergency use of tigecycline in the appropriate clinical situations.", "condition": ["Gram-Positive Bacterial Infections", "Cross Infection"], "intervention_type": ["Drug"], "intervention_name": ["Tigecycline"], "criteria": "Inclusion Criteria: - Male or female subjects, \u2265 8 years of age and a weight of \u2265 35 kilograms - Subjects with selected culture-positive infections caused by a multiple antibiotic-resistant pathogen presumed to be susceptible to tigecycline - Subjects who have failed or are intolerant of other available appropriate antibiotic therapies or whose pathogens are resistant to other available antibiotics Exclusion Criteria: - Subjects who are moribund with an expected survival of less than 2 weeks. - Subjects who have been designated as \"Do Not Resuscitate\", unless it is anticipated within a reasonable degree of medical certainty that they can achieve benefit from potentially curative antibiotic therapy - Known or suspected hypersensitivity to tigecycline, tetracyclines, or other compounds related to this class of antibacterial agents", "gender": "All", "minimum_age": "8 Years", "maximum_age": "N/A", "healthy_volunteers": "No", "keyword": "Bacterial Infections", "mesh_term": ["Infection", "Communicable Diseases", "Bacterial Infections", "Intraabdominal Infections", "Gram-Positive Bacterial Infections", "Cross Infection", "Imipenem", "Tigecycline", "Minocycline", "Cilastatin"], "id": "NCT00081744"}